Grant Bischof
Physician Assistant · Pinehurst, NCNPI 1306467709
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by AbbVie at 49.2% of the total. 2025 is the largest year on record at $15,438, more than ten times the $613 reported in 2021. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 777 payments — averaging $32.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$12K
- TG Therapeutics, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$762
- Pfizer$719
- Novartis$715
- UCB, Inc.$628
- plus $9K from 54 others
What the payments were for
- Speaking & faculty fees$10,83143%
- Travel & lodging$1891%
- Food & beverage$14,04056%
- Education$870%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$7,454
- UBRELVY$3,350
- BRIUMVI$267
- KISUNLA$125
- Austedo XR$120
How this compares
$25,147 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Kesimpta PenOfatumumab | 49 | $517,514 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 17 | $472,622 |
| AustedoDeutetrabenazine | 14 | $191,991 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 29 | $154,721 |
| Nurtec OdtRimegepant Sulfate | 78 | $125,488 |
| NuplazidPimavanserin Tartrate | 21 | $108,365 |
| UbrelvyUbrogepant | 44 | $82,956 |
| Austedo XrDeutetrabenazine | 11 | $61,941 |
| NuedextaDextromethorphan Hbr/Quinidine | 38 | $58,542 |
| Aimovig AutoinjectorErenumab-Aooe | 49 | $42,916 |
| GlatopaGlatiramer Acetate | 19 | $34,271 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 29 | $33,227 |
| Topiramate ErTopiramate | 11 | $25,894 |
| Emgality PenGalcanezumab-Gnlm | 23 | $24,809 |
| NeuproRotigotine | 24 | $19,105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $247 | $472,62217 claims |
| PfizerOctagam, Nurtec Odt, Dilantin | $719 | $284,849118 claims |
| Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr | $762 | $253,93225 claims |
| Acadia Pharmaceuticals IncNuplazid | $286 | $108,36521 claims |
| AbbVieUbrelvy | $12,378 | $82,95644 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $18 | $58,54238 claims |
| UCB, Inc.Neupro | $628 | $19,10524 claims |
| Upsher-smith Laboratories LLCTopiramate | $100 | $4,400297 claims |
| Amneal Pharmaceuticals LLCMycophenolate Mofetil | $393 | $3,75731 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Pinehurst
- Robert ThomasPinehurst$60K
- Sara EbelPinehurst$22K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.